HealthEquity, Inc. (NASDAQ:HQY – Get Rating) has received a consensus rating of "Moderate Buy" from the sixteen research firms that are covering the firm, Marketbeat.com reports. Two analysts have rated the stock with a sell rating, one has given a hold rating and ten have assigned a buy rating to the company. The average 12-month price target among analysts that have issued a report on the stock in the last year is $75.36.

Several equities research analysts have weighed in on the company. KeyCorp assumed coverage on HealthEquity in a report on Thursday. They set an "overweight" rating and a $85.00 price target on the stock. Raymond James upped their target price on HealthEquity from $70.00 to $75.00 and gave the company an "outperform" rating in a research report on Monday, September 12th. Wells Fargo & Company upped their price objective on HealthEquity from $95.00 to $100.00 and gave the company an "overweight" rating in a research note on Tuesday, September 13th. Deutsche Bank Aktiengesellschaft upped their price objective on HealthEquity from $67.00 to $68.00 and gave the company a "buy" rating in a research note on Thursday, September 8th. Finally, SVB Leerink upped their price objective on HealthEquity from $67.00 to $76.00 and gave the company an "outperform" rating in a research note on Tuesday, June 7th.

Insider Buying and Selling at HealthEquity

In other HealthEquity news, COO Edward Bloomberg sold 1,000 shares of the firm's stock in a transaction dated Monday, August 1st. The stock was sold at an average price of $57.63, for a total value of $57,630.00. Following the transaction, the chief operating officer now directly owns 59,850 shares of the company's stock, valued at $3,449,155.50. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 2.80% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On HealthEquity

HealthEquity Stock Down 1.7 %

NASDAQ:HQY opened at $71.36 on Monday. HealthEquity has a 52 week low of $36.81 and a 52 week high of $73.29. The company has a market capitalization of $6.03 billion, a P/E ratio of -96.43, a P/E/G ratio of 4.25 and a beta of 0.90. The stock's fifty day moving average is $62.01 and its two-hundred day moving average is $62.38.

HealthEquity (NASDAQ:HQY – Get Rating) last posted its quarterly earnings data on Tuesday, September 6th. The company reported $0.33 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.33. HealthEquity had a positive return on equity of 2.86% and a negative net margin of 7.82%. During the same period in the prior year, the firm posted $0.21 EPS. Sell-side analysts anticipate that HealthEquity will post 0.69 earnings per share for the current fiscal year.

HealthEquity Company Profile

(Get Rating)

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Featured Articles

• Get a free copy of the StockNews.com research report on HealthEquity (HQY)
• Kroger's is Your One-Stop Consumer Staples Stock
• Adobe Perfects the Art of the Faceplant for Investors
• Tax Credits are the Incentives in the Inflation Reduction Act
• Stock Market: 3 Islands Of Strength In A Sea Of Red
• 3 Banks Worth Considering For Q4

Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.